Literature DB >> 21364533

Atrial fibrillation: AVRO--were the results a surprise?

Soraya M Samii1, Gerald V Naccarelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21364533     DOI： 10.1038/nrcardio.2011.29

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  8 in total

1.  A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.

Authors:  A John Camm; Alessandro Capucci; Stefan H Hohnloser; Christian Torp-Pedersen; Isabelle C Van Gelder; Brian Mangal; Gregory Beatch
Journal:  J Am Coll Cardiol       Date:  2011-01-18       Impact factor: 24.094

2.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

3.  Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.

Authors:  Jacek Cybulski; Piotr Kułakowski; Andrzej Budaj; Henryk Danielewicz; Janusz Maciejewicz; Teresa Kawka-Urbanek; Leszek Ceremuzyński
Journal:  Clin Cardiol       Date:  2003-07       Impact factor: 2.882

4.  Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.

Authors:  Peter R Kowey; Paul Dorian; L Brent Mitchell; Craig M Pratt; Denis Roy; Peter J Schwartz; Jerzy Sadowski; Dorota Sobczyk; Andrzej Bochenek; Egon Toft
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

Review 5.  Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation.

Authors:  Gerald V Naccarelli; Deborah L Wolbrette; Soraya Samii; Javier E Banchs; Erica Penny-Peterson; Robert Stevenson; Mario D Gonzalez
Journal:  Expert Opin Investig Drugs       Date:  2008-05       Impact factor: 6.206

6.  Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.

Authors:  Denis Roy; Craig M Pratt; Christian Torp-Pedersen; D George Wyse; Egon Toft; Steen Juul-Moller; Tonny Nielsen; S Lind Rasmussen; Ian G Stiell; Benoit Coutu; John H Ip; Edward L C Pritchett; A John Camm
Journal:  Circulation       Date:  2008-03-10       Impact factor: 29.690

7.  Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.

Authors:  Craig M Pratt; Denis Roy; Christian Torp-Pedersen; D George Wyse; Egon Toft; Steen Juul-Moller; Enrique Retyk; David Humphrey Drenning
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

8.  Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.

Authors:  E Galve; T Rius; R Ballester; M A Artaza; J M Arnau; D García-Dorado; J Soler-Soler
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.